Daniel Schwartz Selected Research

Daniel Schwartz Research Topics

Disease

2	Proteinuria 01/2022 - 01/2022
2	Cardiomyopathies (Cardiomyopathy) 12/2020 - 10/2019
2	Tuberculosis (Tuberculoses) 01/2020 - 04/2010
2	Glioma (Gliomas) 01/2018 - 12/2016
2	Neoplasms (Cancer) 12/2016 - 03/2010
2	Heart Failure 06/2015 - 01/2014
1	Atrophy 01/2022
1	Lipoprotein Glomerulopathy 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	HIV Infections (HIV Infection) 01/2020
1	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2020
1	Transthyretin-Related Hereditary Amyloidosis 10/2019
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Neuroinflammatory Diseases 01/2019
1	Anaphylaxis (Anaphylactic Shock) 01/2017
1	Cushing Syndrome 01/2017
1	Schizophrenia (Dementia Praecox) 05/2014
1	Teratocarcinoma 05/2014
1	Cardiogenic Shock 01/2014
1	alpha 1-Antitrypsin Deficiency (alpha 1 Antitrypsin Deficiency) 01/2014
1	Hemochromatosis (Bronze Diabetes) 01/2014
1	Liver Diseases (Liver Disease) 01/2014
1	Optic Atrophy 11/2013
1	Retrograde Degeneration 11/2013
1	Hypertension (High Blood Pressure) 12/2012
1	Tachycardia (Tachyarrhythmias) 12/2012
1	Hallucinations (Hallucination) 12/2012
1	Dyspnea (Shortness of Breath) 12/2012
1	Dizziness (Lightheadedness) 12/2012
1	Chronic Renal Insufficiency 12/2012
1	Dysarthria (Spastic Dysarthria) 12/2012
1	Airway Obstruction (Choking) 12/2012
1	Peritonitis 01/2012
1	Sepsis (Septicemia) 01/2012
1	Retinopathy of Prematurity (Retrolental Fibroplasia) 05/2010
1	Melanoma (Melanoma, Malignant) 03/2010
1	Hyperopia (Hypermetropia) 03/2009
1	Cataract (Cataracts) 03/2009
1	Pneumothorax 01/2009
1	Alzheimer Disease (Alzheimer's Disease) 02/2004
1	Stroke (Strokes) 03/2002
1	Sickle Cell Anemia (Hemoglobin S Disease) 03/2002

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 01/2020 - 03/2010
3	Ferrosoferric Oxide (Magnetite)FDA Link 01/2019 - 12/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 01/2012
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 05/2010
2	Contrast MediaIBA 01/2018 - 01/2017
2	Bevacizumab (Avastin)FDA Link 01/2018 - 12/2016
1	ApolipoproteinsIBA 01/2022
1	Apolipoproteins E (ApoE)IBA 01/2022
1	Lipoproteins (Lipoprotein)IBA 01/2022
1	LipidsIBA 01/2022
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2022
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2020
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2020
1	Rituximab (Mabthera)FDA Link 01/2020
1	LactamsIBA 01/2020
1	Amyloid (Amyloid Fibrils)IBA 10/2019
1	GadoliniumIBA 01/2019
1	gadoteridol (Prohance)FDA Link 01/2018
1	Phosphotransferases (Kinase)IBA 01/2017
1	LuciferasesIBA 05/2014
1	Dopamine Receptors (Dopamine Receptor)IBA 05/2014
1	Untranslated Regions (Untranslated Region)IBA 05/2014
1	IronIBA 01/2014
1	Retinaldehyde (Retinal)IBA 11/2013
1	Lidocaine (Xylocaine)FDA LinkGeneric 12/2012
1	Local AnestheticsIBA 12/2012
1	Proteins (Proteins, Gene)FDA Link 04/2010
1	Monoclonal AntibodiesIBA 03/2010
1	Integrin alphaVbeta3IBA 03/2010
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2010
1	AbituzumabIBA 03/2010
1	IntegrinsIBA 03/2010
1	Carrier Proteins (Binding Protein)IBA 02/2004

Therapy/Procedure

4	Therapeutics 01/2019 - 03/2002
1	Heart Transplantation (Grafting, Heart) 06/2015
1	Liver Transplantation 01/2014
1	Traction 11/2013
1	Critical Care (Surgical Intensive Care) 05/2010
1	Intraocular Lenses (Intraocular Lens) 03/2009
1	Decompression 01/2009
1	Thoracostomy 01/2009
1	Blood Transfusion (Blood Transfusions) 03/2002